Literature DB >> 25624740

Rare case of pancreatic cancer with leptomeningeal carcinomatosis.

In Kyung Yoo1, Hong Sik Lee1, Chang Duk Kim1, Hoon Jai Chun1, Yoon Tae Jeen1, Bora Keum1, Eun Sun Kim1, Hyuk Soon Choi1, Jae Min Lee1, Seung Han Kim1, Seung Joo Nam1, Jong Jin Hyun1.   

Abstract

Leptomeningeal carcinomatosis occurs very rarely in patients with pancreatic cancer. Leptomeningeal carcinomatosis is characterized by multifocal seeding of the leptomeninges by malignant cells that originate from a solid tumor. To the best of our knowledge, brain metastasis from pancreatic cancer is extremely rare. Leptomeningeal carcinomatosis is estimated to occur in 3% to 8% of cases of solid tumors. The clinical manifestation usually involves neurological symptoms, including dizziness, headache, vomiting, nausea, and hemiparesis, symptoms similar to those of meningitis or brain tumors. Diagnostic methods for leptomeningeal carcinomatosis include brain magnetic resonance imaging and cerebrospinal fluid examination. Here, we describe a case of leptomeningeal carcinomatosis in which the primary tumor was later determined to be pancreatic cancer. Brain magnetic resonance imaging findings showed mild enhancement of the leptomeninges, and cerebrospinal fluid cytology was negative at first. However, after repeated spinal taps, atypical cells were observed on cerebrospinal fluid analysis and levels of tumor markers such as carbohydrate antigen 19-9 in cerebrospinal fluid were elevated. Abdominal computed tomography, performed to determine the presence of extracerebral tumors, revealed pancreatic cancer. Pancreatic cancer was confirmed histopathologically on examination of an endoscopic ultrasound-guided fine needle aspiration specimen.

Entities:  

Keywords:  Leptomeningeal carcinomatosis; Pancreatic cancer; Prognosis; Radiation therapy; Tumor marker

Mesh:

Substances:

Year:  2015        PMID: 25624740      PMCID: PMC4299319          DOI: 10.3748/wjg.v21.i3.1020

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Leptomeningeal metastases.

Authors:  Santosh Kesari; Tracy T Batchelor
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

Review 2.  The diagnostic and therapeutic management of leptomeningeal carcinomatosis.

Authors:  N Pavlidis
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

Review 3.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

4.  Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2012-04-27       Impact factor: 4.130

5.  Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

6.  Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.

Authors:  Christos Kosmas; Nicolas B Tsavaris; George Tsakonas; Georgia Soukouli; Argyris Gassiamis; Nicolas Mylonakis; Athanasios Karabelis
Journal:  Med Sci Monit       Date:  2005-07-25

7.  [Leptomeningeal carcinomatosis following 27 years remission from breast cancer with epidermoid: a case report].

Authors:  Yousuke Tajima; Kentaro Horiguchi; Shigeki Nakano; Seiichiro Hirono; Yoshinori Higuchi; Takashi Oide; Yasuo Iwadate; Naokatsu Saeki
Journal:  No Shinkei Geka       Date:  2012-04

8.  Leptomeningeal carcinomatosis in gastric cancer.

Authors:  Jae-Lyun Lee; Yoon-Koo Kang; Tae-Won Kim; Heung-Moon Chang; Gyeong-Won Lee; Min-Hee Ryu; Eunkyoung Kim; Seok-Joong Oh; Je-Hwan Lee; Sung-Bae Kim; Sang-We Kim; Cheolwon Suh; Kyoo-Hyung Lee; Jung-Shin Lee; Woo-Kun Kim; Sang-Hee Kim
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

10.  Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival.

Authors:  Anna Niwińska; Halina Rudnicka; Magdalena Murawska
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

View more
  7 in total

Review 1.  Gamma Knife treatment of recurrent CNS metastases of pancreatic origin: a case report and review of the literature.

Authors:  Subha Perni; Tony J Wang; Jerry Lesser; Christopher Mandigo; Steven R Isaacson; David P Horowitz
Journal:  CNS Oncol       Date:  2017-04

2.  Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review.

Authors:  Yuki Ikeda; Makoto Yoshida; Kazuma Ishikawa; Tomohiro Kubo; Kazuyuki Murase; Kohichi Takada; Koji Miyanishi; Junji Kato
Journal:  Int Cancer Conf J       Date:  2020-03-14

Review 3.  Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.

Authors:  Catherine A O'Connor; Jennifer S Park; Thomas Kaley; Brie Kezlarian; Marcia Edelweiss; T Jonathan Yang; Wungki Park; Diane Reidy; Anna M Varghese; Kenneth H Yu; Eileen M O'Reilly
Journal:  Pancreatology       Date:  2021-02-06       Impact factor: 3.996

4.  Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer: A Rare Phenomenon?

Authors:  Taichi Sayanagi; Yumiko Ohishi; Makoto Katayama; Ryota Tamura
Journal:  Medicines (Basel)       Date:  2022-07-12

5.  Brain metastasis in pancreatic cancer: Two case reports.

Authors:  Takashi Sasaki; Tatsuya Sato; Yousuke Nakai; Naoki Sasahira; Hiroyuki Isayama; Kazuhiko Koike
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

6.  Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine.

Authors:  Garry Ceccon; Michael Wollring; Anna Brunn; Martina Deckert; Dirk Waldschmidt; Gereon R Fink; Norbert Galldiks
Journal:  Case Rep Oncol       Date:  2020-01-21

7.  Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.

Authors:  Kunio Iwatsuka; Daiichiro Kikuta; Hitoshi Shibuya; Masahiro Ogawa; Takuji Gotoda; Mitsuhiko Moriyama; Hiroshi Nakagawara; Akihiro Hemmi; Kenji Yamao
Journal:  Intern Med       Date:  2021-06-19       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.